Questions: Apoptosis vs. Necrosis: Molecular Mechanisms and Pathological Consequences

Question 1

A toxin causes necrosis in kidney tubular cells. Which downstream consequence results specifically from necrosis rather than apoptosis?

• A. DNA fragmentation into nucleosome-sized fragments (DNA laddering)
• B. Inflammatory infiltration driven by DAMP release into the extracellular space
• C. Exposure of phosphatidylserine on the outer leaflet of the plasma membrane
• D. Activation of executioner caspases-3 and -7

Answer: (B)

Necrosis causes plasma membrane failure and spillage of intracellular contents — including damage-associated molecular patterns (DAMPs) like HMGB1 and ATP — into the extracellular space. These activate pattern-recognition receptors on innate immune cells, triggering neutrophil recruitment and the inflammatory cascade. The other options are hallmarks of apoptosis: internucleosomal DNA fragmentation, phosphatidylserine exposure as an 'eat-me' signal, and caspase-3/7 activation all occur within the orderly, non-inflammatory apoptotic program.

Question 2

Bcl-2 overexpression in cancer cells confers resistance to many chemotherapy agents. The mechanism is:

• A. Bcl-2 activates the extrinsic pathway, redirecting cells toward necrosis instead of apoptosis
• B. Bcl-2 blocks cytochrome c release from mitochondria, preventing apoptosome formation and intrinsic pathway activation
• C. Bcl-2 degrades caspase-8 before it can activate downstream executioner caspases
• D. Bcl-2 upregulates HMGB1 to protect cells from immune-mediated killing

Answer: (B)

The intrinsic apoptotic pathway depends on mitochondrial outer membrane permeabilization — pro-apoptotic Bax forms pores, releasing cytochrome c, which assembles the apoptosome and activates caspase-9. Bcl-2 directly antagonizes Bax, maintaining mitochondrial membrane integrity and preventing cytochrome c release. When Bcl-2 is overexpressed, chemotherapy-induced cellular stress cannot trigger the cascade, and cells survive. This is why Bcl-2 inhibitors (like venetoclax) were developed as targeted anticancer agents.

Question 3

Necrosis is simply a more severe form of the same programmed cell death machinery as apoptosis, differing primarily in the degree of cellular stress applied.

• T. True
• F. False

Answer: False

Necrosis and apoptosis are qualitatively different processes, not points on a severity spectrum. Apoptosis is an active, ATP-requiring program executed by caspase cascades that maintains membrane integrity and produces phagocytosable apoptotic bodies. Necrosis is passive collapse — it occurs when injury overwhelms the cell's homeostatic capacity, the plasma membrane ruptures, and intracellular contents spill out. Necrosis requires no caspase activation and cannot be blocked by caspase inhibitors. The distinction is mechanistic, not quantitative.

Question 4

Apoptotic cells are cleared without triggering inflammation partly because the plasma membrane remains intact throughout the process, preventing damage-associated molecular patterns from entering the extracellular space.

• T. True
• F. False

Answer: True

This is the key mechanistic reason apoptosis is 'immunologically silent.' DAMPs (HMGB1, ATP, uric acid) are powerful activators of innate immunity when present extracellularly. Apoptosis packages cellular contents into membrane-bound apoptotic bodies before the membrane fails, so DAMPs are never released. Phosphatidylserine exposure on the outer membrane surface signals phagocytes to engulf the apoptotic body cleanly. Necrosis releases the same DAMPs freely, triggering the inflammatory cascade — a qualitatively different tissue outcome.

Question 5

During a myocardial infarction, troponin is detectable in the bloodstream as a diagnostic marker. Explain the cell death mechanism responsible for troponin's release, and why apoptosis would not account for it.

Model answer: Troponin is released because ischemic cardiomyocytes undergo necrosis: ATP depletion and hypoxia cause plasma membrane failure, and intracellular proteins including troponin spill into the bloodstream. Apoptosis would not release troponin into circulation because the apoptotic program maintains plasma membrane integrity throughout — the cell is packaged into apoptotic bodies that are phagocytosed without releasing cytoplasmic contents. The presence of troponin in blood is a specific indicator of necrotic, not apoptotic, cardiac cell death.

Troponin I and T are cardiac-specific isoforms normally confined within cardiomyocytes. Their appearance in blood directly reflects membrane rupture kinetics in necrotic tissue. Apoptotic cell death at the ischemic border zone does not contribute to the troponin rise. This mechanistic distinction underlies why troponin assays are the clinical standard for diagnosing myocardial infarction — they detect necrotic membrane rupture, the hallmark of ischemic necrosis.